Poly(2-ethyl-2-oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility

Polymers in Drug Delivery-State of the Art and Future Trends

(2011) Stefan Grund et al.   ADVANCED ENGINEERING MATERIALS

Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery

(2011) Tacey X. Viegas et al.   BIOCONJUGATE CHEMISTRY

Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles

(2011) Robert Luxenhofer et al.   JOURNAL OF CONTROLLED RELEASE

In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines)

(2011) Juraj Kronek et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

(2010) Katrin Knop et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Biocompatibility Investigation of Polyethylene Glycol and Alginate-Poly-l-Lysine for Islet Encapsulation

(2010) Xiang Y. Liu et al.   ASAIO JOURNAL

T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes

(2010) Hiroyuki Koide et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes

(2009) Tatsuaki Tagami et al.   JOURNAL OF CONTROLLED RELEASE

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

(2008) L. C. Scott et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process

(2008) I. Hamad et al.   MOLECULAR IMMUNOLOGY

Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates?

(2007) Anna Mero et al.   JOURNAL OF CONTROLLED RELEASE